Active Ingredient(s): Brinzolamide
FDA Approved: * April 1, 1998
Pharm Company: * ALCON
Category: Vision / Eye Health

Brinzolamide (trade names Azopt, Alcon Laboratories, Befardin,[2] Fardi Medicals,[3] ) is a carbonic anhydrase inhibitor used to lower intraocular pressure in patients with open-angle glaucoma or ocular hypertension. Brinzolamide was approved as a generic medication in the United States in November 2020.[4] Contents 1 Chemistry 2 Indications 3 Pharmacodynamics 4 Pharmacokinetics 4.1 Absorption 4.2 Distribution 4.3 Metabolism 4.4 Excretion 5... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.
1 Discussion

Dosage List

Azopt 10 mg/ml Ophthalmic Suspension
NDC: 0065-0275
Alcon Laboratories, Inc.
Azopt 10 mg/ml Ophthalmic Suspension/ Drops
NDC: 0078-0722
Novartis Pharmaceuticals Corporation

Popular Topics

Azopt Side Effects

What issues have you had with Azopt? ## Hello, DPGirl! How are you? The FDA has approved Azopt to treat increased pressu...